Bispecific Autoantigen-T Cell Engagers (BAITE) Pitch

Описание к видео Bispecific Autoantigen-T Cell Engagers (BAITE) Pitch

First-in-class precision immunotherapies for autoimmune diseases. Selective depletion of autoreactive B cells with wide applicability across autoimmune and rheumatic diseases (e.g., antiphospholipid syndrome, lupus, rheumatoid arthritis). Normal immune cells are spared, eliminating risk of infection . Treatment of mild disease or even preclinical autoimmunity possible. Off-the-shelf, no need for conditioning, and maximally scalable
Innovator: Maximilian Konig, M.D.

Комментарии

Информация по комментариям в разработке

Похожие видео